Harnessing mutual exclusivity between TP53 and ARID1 A mutations

Shuai WuGene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, USA

Nail FatkhutdinovGene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, USA;Kazan Federal University, Kazan, Russia

Rugang ZhangGene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, USACorrespondence[email protected]

References

Jones S, Wang TL, Shih IeM, Mao TL, Nakayama K, Roden R, Glas R, Slamon D, Diaz LA Jr, Vogelstein B, Kinzler KW, Velculescu VE, et al. Frequent mutations of chromatin remodeling gene ARID1 A in ovarian clear cell carcinoma. Science. 2010;330:228-31. doi: 10.1126/science.1196333. PMID: 20826764
PubMed Web of Science ®Google Scholar
Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, et al. ARID1 A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010;363:1532-43. doi: 10.1056/NEJMoa1008433. PMID: 20942669
PubMed Web of Science ®Google Scholar
Guan B, Wang TL, Shih IeM. ARID1 A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res. 2011;71:6718-27. doi:10.1158/0008-5472.CAN-11-1562. PMID: 21900401
PubMed Web of Science ®Google Scholar
Bitler BG, Wu S, Park PH, Hai Y, Aird KM, Wang Y, Zhai Y, Kossenkov AV, Vara-Ailor A, Rauscher Iii FJ, et al. ARID1 A-mutated ovarian cancers depend on HDAC6 activity. Nat Cell Biol. 2017;19:962-73. doi: 10.1038/ncb3582. PMID: 28737768
PubMed Web of Science ®Google Scholar
Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer. 2011;11:481-92. doi: 10.1038/nrc3068. PMID: 21654818
PubMed Web of Science ®Google Scholar
Bitler BG, Aird KM, Garipov A, Li H, Amatangelo M, Kossenkov AV, Schultz DC, Liu Q, Shih IeM, Conejo-Garcia JR, Speicher DW, et al. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1 A-mutated cancers. Nat Med. 2015;21:231-8. doi: 10.1038/nm.3799. PMID: 25686104
PubMed Web of Science ®Google Scholar
Howitt BE, Strickland KC, Sholl LM, Rodig S, Ritterhouse LL, Chowdhury D, D'Andrea AD, Matulonis UA, Konstantinopoulos PA. Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression. Oncoimmunology. 2017;6:e1277308. doi:10.1080/2162402X.2016.1277308. PMID: 28344892
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Harnessing mutual exclusivity between TP53 and ARID1 A mutations

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Harnessing mutual exclusivity between TP53 and ARID1 A mutations

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date